This approval, along with its existing indications for adults with type 2 diabetes to improve glycemic control and to reduce the risk of major cardiovascular events in adults also with known heart disease, establishes Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg as the most broadly indicated glucagon-like peptide-1 receptor agonist (GLP-1 RA) in its class
Tracking symptoms is less about just keeping medical records and more about gaining personal clarity
Whitehouse Station, NJ: Merck & Co
Adverse reactions reported following methylcobalamin administration include headache, infection, nausea/vomiting, paresthesias, and rhinitis
Data presented is the arithmetic mean of three independent experiments
While Ozempic is an effective treatment for type 2 diabetes, it may be associated with an increased risk of pancreatitis